Category: US MSOs
-
Plus Products (PLUS.C) sheds short-term gain for long-term profitability in CPG segment
Plus Products (PLUS.C) is a proponent of the hyper-specialization approach in a sector which, at least once upon a time, prided itself on vertical integration across a wide swathe of products. The company operates in California and Nevada, selling their consumer packaged goods (CPG) edible products which include gummies, mints and more. A respectable cash…
-
Navigating the cannapocalypse through value picks: Don’t be swayed by optimists or cynics
Yesterday, weed stocks were generally green. The day before too. This brought about a load of folks on social media talking about how ‘cannabis is back!’ and ‘the bear market is over!’ Ugh. Seriously, you guys. It’s not over. Not by a long shot. Currently, Canopy Growth Corp (WEED.T), the big bellwether of the cannabis…
-
Kushco Holdings’ (KSHB.Q) gets 37% down with the sickness because of trash financing, right?
Kushco Holdings (KSHB.Q) saw its stock drop 37% today, and although nobody knows why for certain, it’s clear there’s a sickness here somewhere. To set the scene, Kushco Holdings is cannabis-related company, and they just announced a new financing. Normally, there’s nothing spectacular about that (for better or worse) but the story goes deeper. Kushco…
-
The cannabis bubble Canopy Growth (WEED.T) created is now the tsunami killing everyone
The cannabis bubble is not yet bursting, but the likelihood that it will go by the time you read this is high. The markets are wobbling hard for a multitude of reasons, but the cannabis sector is reeling because the bellwether cannabis stock, Canopy Growth Corp (WEED.T) is in freefall. Other companies that exist as…
-
Maple Leaf Green World (MGW.E) couldn’t afford a 2010 Jeep Wrangler according to latest financials
Maple Leaf Green World (MGW.E) has just posted its latest financials for Q2 2019, showing a drastic decrease in cash assets and a looming equity deficit sure to concern investors. The company reported cash and cash equivalents totaling $16,920, a significant decrease from the $109,000 in cash Maple Leaf reported at the end of Q1 2019…
-
Sol Global (SOL.C): The only weed company I know that lists ‘divestments’ on its website
Andy DeFrancesco is the devil. Just ask anyone. The worst guy in the weed business, the archangel of bad asset deals, the shell master of Florida. He’s got investigative journalists who write about nothing other than him, he’s got shareholders at various companies that have bought things from him screaming at him for taking their…
-
Marijuana update: No, the market isn’t getting killed… we’re just not rewarding bullshit anymore
Top tip: You guys out there whining about ‘the market’ being down are finding excuses for the wrong problem. Folks be running about with their hair on fire right now, pointing to a sky that for sure is falling because a few of their favourite weed stocks have come off absurd highs and what if…
-
Hemptown Organics opens financing to non-accredited investors
A few years ago, we wrote one of our defining pieces at Equity.Guru, an article that opened a new world up for a variety of investors, and introduced them to a pre-public listing deal that, for a change, was opening up to the little guy. So you missed Canopy/Tweed coming to the market. You stood…
-
What the FDA thinks of Curaleaf (CURA.C), the ‘world’s largest cannabis co.’
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused products are “in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act,” and Curaleaf’s CBD products for pets are “unapproved new…